GARRETT GAILLARD: Open Payments
NPI 1952899510 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 18 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $181 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $177 |
| PFIZER INC. | 5 | $116 |
| Amgen Inc. | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| SANOFI PASTEUR INC. | 1 | $26 |
| C2N Diagnostics, LLC | 1 | $22 |
Products named: KISUNLA, MOUNJARO, ELIQUIS, OTEZLA, VYNDAQEL, PREVNAR 20, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, BREZTRI.
Industry payments across RI — which companies pay providers there.
